Skip to main content

Table 3 Rate Ratio and Rate Difference per 10,000 person-years, for incident type 2 diabetes (95%CI) comparing the 90th to the 10th percentiles of HLS-related metabolites distributionsa

From: Healthy lifestyle, metabolomics and incident type 2 diabetes in a population-based cohort from Spain

Ā 

RR (95% CI)

RD (95%CI)

Group

Metabolite

Model 1

p-value

Model 2

p-value

Model 1

p-value

Model 2

p-value

Lipoprotein profile

Cholesterol

ā€ƒVLDL cholesterol

2.12 (1.45ā€“3.08)

<ā€‰0.001

2.09 (1.35ā€“3.24)

<ā€‰0.001

59.62 (18.18, 101.06)

0.005

60.66 (16.58, 104.74)

0.007

ā€ƒHDL cholesterol

0.21 (0.07ā€“0.66)

0.008

0.28 (0.10ā€“0.79)

0.02

āˆ’52.40 (āˆ’88.35, āˆ’16.45)

0.004

āˆ’ā€‰47.56 (āˆ’ā€‰83.74, āˆ’ā€‰11.37)

0.01

ā€ƒIDL cholesterol

1.27 (0.75ā€“2.15)

0.38

1.11 (0.61ā€“2.01)

0.74

9.82 (āˆ’ā€‰15.46, 35.1)

0.45

6.12 (āˆ’24.57, 36.81)

0.70

Triglycerides

ā€ƒVLDL triglycerides

2.07 (1.48ā€“2.91)

<ā€‰0.001

2.02 (1.38ā€“2.95)

<ā€‰0.001

58.25 (17.54, 98.95)

0.005

56.59 (14.06, 99.12)

0.009

ā€ƒIDL triglycerides

1.25 (0.69ā€“2.29)

0.46

1.14 (0.60ā€“2.17)

0.69

9.79 (āˆ’18.15, 37.73)

0.49

8.52 (āˆ’22.84, 39.89)

0.59

Lipoprotein particle concentration

ā€ƒLarge VLDL

1.77 (1.36ā€“2.31)

<ā€‰0.001

1.67 (1.25ā€“2.24)

<ā€‰0.001

48.30 (8.03, 88.58)

0.02

45.59 (4.49, 86.69)

0.03

ā€ƒMedium VLDL

1.56 (1.20ā€“2.03)

<ā€‰0.001

1.48 (1.12ā€“1.95)

<ā€‰0.001

43.70 (8.93, 78.48)

0.01

39.86 (3.85, 75.87)

0.03

ā€ƒSmall VLDL

2.34 (1.62ā€“3.37)

<ā€‰0.001

2.40 (1.57ā€“3.68)

<ā€‰0.001

61.85 (20.86, 102.85)

0.003

62.69 (19.54, 105.84)

0.004

ā€ƒSmall LDL

1.70 (1.20ā€“2.40)

0.003

2.71 (1.52ā€“4.82)

<ā€‰0.001

45.69 (6.59, 84.78)

0.02

78.19 (16.82, 139.56)

0.01

ā€ƒMedium HDL

0.15 (0.05ā€“0.49)

0.002

0.22 (0.07ā€“0.66)

0.007

āˆ’54.12 (āˆ’84.41, āˆ’23.83)

<ā€‰0.001

āˆ’46.41 (āˆ’76.50, āˆ’16.31)

0.003

Amino acids

Alanine

0.33 (0.20ā€“0.53)

<ā€‰0.001

0.38 (0.24ā€“0.60)

<ā€‰0.001

āˆ’66.25 (āˆ’ā€‰106.80, āˆ’ā€‰25.70)

0.001

āˆ’60.72 (āˆ’ā€‰100.87, āˆ’ā€‰20.58)

0.003

Creatine phosphate

0.43 (0.22ā€“0.84)

0.01

0.36 (0.18ā€“0.76)

0.007

āˆ’36.60 (āˆ’ā€‰70.68, āˆ’ā€‰2.52)

0.04

āˆ’51.06 (āˆ’95.96, āˆ’ā€‰6.15)

0.03

Creatine

0.34 (0.20ā€“0.59)

<ā€‰0.001

0.27 (0.14ā€“0.51)

<ā€‰0.001

āˆ’49.69 (āˆ’ā€‰82.80, āˆ’ā€‰16.57)

0.003

āˆ’68.15 (āˆ’113.77, āˆ’ā€‰22.52)

0.003

Cysteine

0.35 (0.20ā€“0.60)

<ā€‰0.001

0.29 (0.15ā€“0.55)

<ā€‰0.001

āˆ’43.89 (āˆ’ā€‰74.10, āˆ’ā€‰13.69)

0.004

āˆ’57.78 (āˆ’97.34, āˆ’ā€‰18.21)

0.004

Glutamine

0.32 (0.18ā€“0.57)

<ā€‰0.001

0.29 (0.15ā€“0.53)

<ā€‰0.001

āˆ’ā€‰51.97 (āˆ’88.04, āˆ’15.91)

0.005

āˆ’62.53 (āˆ’ā€‰106.14, āˆ’ā€‰18.91)

0.005

N-acetylglutamine

0.28 (0.18ā€“0.44)

<ā€‰0.001

0.27 (0.16ā€“0.44)

<ā€‰0.001

āˆ’ā€‰68.69 (āˆ’104.62, āˆ’ā€‰32.76)

<ā€‰0.001

āˆ’71.46 (āˆ’109.90, āˆ’ā€‰33.01)

<ā€‰0.001

Proline

0.34 (0.19ā€“0.62)

<ā€‰0.001

0.33 (0.18ā€“0.61)

<ā€‰0.001

āˆ’ā€‰51.58 (āˆ’ā€‰88.78, āˆ’14.37)

0.007

āˆ’58.68 (āˆ’ā€‰100.91, āˆ’ā€‰16.44)

0.006

Leucine

0.32 (0.20ā€“0.51)

<ā€‰0.001

0.37 (0.23ā€“0.59)

<ā€‰0.001

āˆ’68.75 (āˆ’107.06, āˆ’ā€‰30.45)

<ā€‰0.001

āˆ’60.81 (āˆ’ā€‰97.75, āˆ’ā€‰23.87)

0.001

Fatty acids

CH2CH2CO-

3.38 (2.07ā€“5.52)

<ā€‰0.001

3.03 (1.87ā€“4.91)

<ā€‰0.001

64.57 (27.25, 101.89)

<ā€‰0.001

60.88 (24.37, 97.39)

0.001

CH2N-

2.79 (1.69ā€“4.60)

<ā€‰0.001

2.77 (1.62ā€“4.73)

<ā€‰0.001

53.28 (17.86, 88.69)

0.003

59.06 (18.42, 99.70)

0.004

Isobutyrate

0.22 (0.13ā€“0.37)

<ā€‰0.001

0.27 (0.16ā€“0.46)

<ā€‰0.001

āˆ’73.15 (āˆ’ā€‰109.93, āˆ’ā€‰36.38)

<ā€‰0.001

āˆ’65.92 (āˆ’101.30, āˆ’ā€‰30.54)

<ā€‰0.001

Fluid balance

Albumin

0.34 (0.20ā€“0.58)

<ā€‰0.001

0.26 (0.14ā€“0.50)

<ā€‰0.001

āˆ’50.89 (āˆ’ā€‰84.27, āˆ’17.52)

0.003

āˆ’70.49 (āˆ’ā€‰116.19, āˆ’ā€‰24.78)

0.003

Creatinine

0.65 (0.34ā€“1.26)

0.21

0.56 (0.26ā€“1.17)

0.12

āˆ’ā€‰16.96 (āˆ’ā€‰46.61, 12.68)

0.26

āˆ’22.07 (āˆ’ā€‰56.62, 12.49)

0.21

Energy metabolism

Glycolysis

ā€ƒCitrate

0.30 (0.16ā€“0.57)

<ā€‰0.001

0.27 (0.14ā€“0.55)

<ā€‰0.001

āˆ’49.90 (āˆ’ā€‰84.40, āˆ’ā€‰15.40)

0.005

āˆ’ā€‰58.56 (āˆ’98.87, āˆ’ā€‰18.26)

0.004

ā€ƒPyruvate

0.32 (0.18ā€“0.59)

<ā€‰0.001

0.31 (0.16ā€“0.58)

<ā€‰0.001

āˆ’ā€‰49.48 (āˆ’ā€‰84.04, āˆ’ā€‰14.92)

0.005

āˆ’ā€‰56.04 (āˆ’94.75, āˆ’ā€‰17.32)

0.005

Ketone bodies

ā€ƒAcetate

0.28 (0.15ā€“0.52)

<ā€‰0.001

0.27 (0.15ā€“0.51)

<ā€‰0.001

āˆ’ā€‰62.62 (āˆ’ā€‰101.68, āˆ’ā€‰23.55)

0.002

āˆ’ā€‰68.92 (āˆ’ā€‰111.80, āˆ’ā€‰26.04)

0.002

ā€ƒAcetone

3.19 (1.97ā€“5.15)

<ā€‰0.001

2.88 (1.84ā€“4.51)

<ā€‰0.001

75.63 (32.20, 119.05)

<ā€‰0.001

72.26 (29.49, 115.03)

<ā€‰0.001

ā€ƒ3-Hydroxybutyrate

0.36 (0.20ā€“0.64)

<ā€‰0.001

0.34 (0.18ā€“0.63)

<ā€‰0.001

āˆ’ā€‰48.61 (āˆ’ā€‰84.22, āˆ’ā€‰13.00)

0.007

āˆ’ā€‰56.27 (āˆ’ā€‰97.80, āˆ’ā€‰14.74)

0.008

Products of bacterial co-metabolism

Isopropanol

0.47 (0.23ā€“0.93)

0.03

0.39 (0.18ā€“0.85)

0.02

āˆ’31.46 (āˆ’ā€‰63.24, 0.31)

0.05

āˆ’43.23 (āˆ’ā€‰83.80, āˆ’ā€‰2.66)

0.04

Trimethylamines

0.29 (0.16ā€“0.53)

<ā€‰0.001

0.23 (0.12ā€“0.45)

<ā€‰0.001

āˆ’52.59 (āˆ’ā€‰86.57, āˆ’ā€‰18.61)

0.002

āˆ’68.58 (āˆ’ā€‰112.14, āˆ’ā€‰25.01)

0.002

Phenylpropionate

0.34 (0.21ā€“0.54)

<ā€‰0.001

0.39 (0.26ā€“0.59)

<ā€‰0.001

āˆ’ā€‰70.33 (āˆ’ā€‰112.40, āˆ’ā€‰28.25)

0.001

āˆ’66.12 (āˆ’ā€‰108.06, āˆ’ā€‰24.19)

0.002

Phosphoethanolamines

O-phosphoethanolamine

0.38 (0.20ā€“0.72)

0.003

0.33 (0.17ā€“0.65)

0.002

āˆ’ā€‰42.53 (āˆ’ā€‰77.86, āˆ’7.19)

0.02

āˆ’56.54 (āˆ’ā€‰101.38, āˆ’ā€‰11.69)

0.01

  1. Abbreviations: RR rate ratio; RD rate difference; CI confidence interval. a nā€‰=ā€‰830
  2. Model 1 was adjusted for age (years), sex (men, women) and education (ā‰¤ high school, > high school). Model 2 was model 1 additionally adjusted for prevalent hypertension (no, yes), total plasma cholesterol (mg/dL) and use of lipid lowering medication (no, yes)